Palo Capital Has Lifted By $348,591 Its F5 Networks (FFIV) Stake; Nxstage Medical (NXTM) Has 1.25 Sentiment

May 18, 2018 - By Ina Campbell

F5 Networks, Inc. (NASDAQ:FFIV) Logo

Palo Capital Inc increased F5 Networks Inc (FFIV) stake by 21.07% reported in 2017Q4 SEC filing. Palo Capital Inc acquired 2,661 shares as F5 Networks Inc (FFIV)’s stock rose 9.51%. The Palo Capital Inc holds 15,293 shares with $2.01 million value, up from 12,632 last quarter. F5 Networks Inc now has $10.46 billion valuation. The stock increased 0.06% or $0.1 during the last trading session, reaching $171.14. About 370,289 shares traded. F5 Networks, Inc. (NASDAQ:FFIV) has declined 1.06% since May 18, 2017 and is downtrending. It has underperformed by 12.61% the S&P500.

Nxstage Medical Inc (NXTM) investors sentiment increased to 1.25 in 2017 Q4. It’s up 0.34, from 0.91 in 2017Q3. The ratio is more positive, as 79 investment managers increased or started new holdings, while 63 decreased and sold equity positions in Nxstage Medical Inc. The investment managers in our database now possess: 47.78 million shares, down from 51.56 million shares in 2017Q3. Also, the number of investment managers holding Nxstage Medical Inc in top ten holdings increased from 3 to 7 for an increase of 4. Sold All: 22 Reduced: 41 Increased: 48 New Position: 31.

Burren Capital Advisors Ltd holds 4.82% of its portfolio in Nxstage Medical, Inc. for 33,550 shares. Falcon Edge Capital Lp owns 791,000 shares or 4.39% of their US portfolio. Moreover, Pennant Capital Management Llc has 3.86% invested in the company for 1.76 million shares. The New Jersey-based Alpine Associates Management Inc. has invested 3.5% in the stock. Dafna Capital Management Llc, a California-based fund reported 216,119 shares.

More news for Nxstage Medical, Inc. (NASDAQ:NXTM) were recently published by: Fool.com, which released: “NxStage Keeps Losing Money as Key Deadline Grows Nearer” on May 14, 2018. Globenewswire.com‘s article titled: “Consolidated Research: 2018 Summary Expectations for The Mosaic, Newmont Mining, National Oilwell Varco …” and published on May 08, 2018 is yet another important article.

Since January 1, 0001, it had 0 insider purchases, and 2 selling transactions for $172,760 activity.

The stock decreased 1.06% or $0.28 during the last trading session, reaching $26.2. About 133,257 shares traded. Nxstage Medical, Inc. (NXTM) has declined 9.81% since May 18, 2017 and is downtrending. It has underperformed by 21.36% the S&P500.

NxStage Medical, Inc., a medical technology company, develops, makes, and markets services and products for patients suffering from chronic or acute kidney failure. The company has market cap of $1.74 billion. The Company’s primary product includes the System One, a portable hemodialysis system, which is used primarily for home hemodialysis and a range of dialysis therapies to deliver in the home setting. It currently has negative earnings. The firm operates through three divisions: System One, In-Center, and Services.

Among 39 analysts covering F5 Networks Inc. (NASDAQ:FFIV), 10 have Buy rating, 2 Sell and 27 Hold. Therefore 26% are positive. F5 Networks Inc. had 114 analyst reports since July 24, 2015 according to SRatingsIntel. RBC Capital Markets downgraded F5 Networks, Inc. (NASDAQ:FFIV) rating on Thursday, October 29. RBC Capital Markets has “Sector Perform” rating and $125 target. As per Friday, November 13, the company rating was downgraded by JMP Securities. Zacks downgraded F5 Networks, Inc. (NASDAQ:FFIV) on Thursday, September 3 to “Hold” rating. The rating was downgraded by Zacks to “Buy” on Thursday, August 20. The stock of F5 Networks, Inc. (NASDAQ:FFIV) earned “Buy” rating by J.P. Morgan on Thursday, May 3. The stock has “Buy” rating by Drexel Hamilton on Thursday, July 27. The stock has “Neutral” rating by M Partners on Tuesday, December 22. The stock of F5 Networks, Inc. (NASDAQ:FFIV) earned “Buy” rating by DA Davidson on Friday, August 12. M Partners maintained it with “Neutral” rating and $118 target in Wednesday, June 8 report. Oppenheimer downgraded the stock to “Perform” rating in Tuesday, January 5 report.

More important recent F5 Networks, Inc. (NASDAQ:FFIV) news were published by: Benzinga.com which released: “F5 Networks Q2 Earnings Preview” on April 25, 2018, also Globenewswire.com published article titled: “Report: Exploring Fundamental Drivers Behind Gartner, F5 Networks, Medidata Solutions, Evertec, Ring Energy, and …”, Benzinga.com published: “Benzinga’s Top Upgrades, Downgrades For May 16, 2018” on May 16, 2018. More interesting news about F5 Networks, Inc. (NASDAQ:FFIV) was released by: 247Wallst.com and their article: “Top Analyst Upgrades and Downgrades: 3M, AMD, CenturyLink, Chipotle, F5 Networks, Raymond James, Symantec …” with publication date: May 16, 2018.

Since February 1, 2018, it had 0 buys, and 17 sales for $20.13 million activity. MCADAM JOHN sold 25,000 shares worth $3.60 million. Reinland Andrew also sold $288,933 worth of F5 Networks, Inc. (NASDAQ:FFIV) on Thursday, February 1. Shares for $289,014 were sold by HIGGINSON ALAN. $239,281 worth of stock was sold by Locoh-Donou Francois on Friday, February 2. Kearny Ryan C. also sold $1.09M worth of F5 Networks, Inc. (NASDAQ:FFIV) on Thursday, February 1. Another trade for 1,769 shares valued at $287,615 was made by DiLullo John D on Tuesday, May 1. The insider Rogers Scot Frazier sold 2,738 shares worth $396,540.

F5 Networks, Inc. (NASDAQ:FFIV) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: